Breadcrumb
The International Society of Hypertension honours the RI-MUHC...
Congratulations to Dr. Julia Valdemarin Burnier!
Topic: Developing a core outcome set for diabetes after pregnancy prevention trials: the COS-DAP project
The meaning of recovery goes beyond traditional clinical parameters
Experts at the CIM technology platforms are on site to support clinical research
Topic: Variance Modeling with the Mixed Effects Location Scale (MELS) Model for Ecological Momentary Assessment (EMA) Data
Topic: Empowering people living with Human Immunodeficiency Virus using mHealth
Changing our understanding of childhood brain tumours and how to treat them
Dr. Foster succeeds Dr. Michael Shevell effective September 1, 2021
Message from the Executive Director
About us
Honours and awards
Dialysis patients do not develop adequate antibodies with one dose of SARS-CoV-2 vaccine
Topic: Innovation in diagnostics with a focus on COVID-19
RI-MUHC Annual Reports
The Government of Quebec honours her outstanding contributions to cancer research
Results published in JAMA Network Open may change practice for young infants with fever
Funding results CIHR CLINICAL TRIALS PROJECTS – SECOND ROUND (2024)SPRING 2024 CIHR COMPETITION RESULTSCANADA RESEARCH CHAIRS, SPRING...
Congratulations to RI-MUHC researchers who received FRQS salary awards!
Topic: The Retinoic Acid Receptor-Related Orphan Receptor (RORγt)—A Potential Key Transcription Factor in Cancer Resistance
Administrative Services
More than a research hospital: A hospital driven by research!
Keynote speaker: Dr. Hideki Ueno, MD, PhD
Topic: Why isn’t Gut inflammation more common?